Body na spoluautora | Body za publikaci pro MU | Odkaz ISVaV | 3,40 | 16,99 | Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status
|
8,22 | 65,73 | When one chip is not enough: Augmenting the validity of SELDI-TOF proteomic profiles of clinical specimens
|
9,31 | 65,14 | Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast
|
0,89 | 7,14 | Identification of alphaB-crystallin, a biomarker of renal cell carcinoma by SELDI-TOF MS
|
0,00 | 0,00 | Využití průtokové cytometrie pro sledování proliferace a diferenciace monoblastů transformovaných onkogenem v-myb
|
0,00 | 0,00 | Nádorový supresor p53 zastavuje proliferaci a indukuje diferenciaci monoblastů BM2
|
0,00 | 0,00 | p53 tumor suppressor inhibits proliferation and induces differentiation of v-myb-transformed monoblasts
|
0,97 | 5,82 | MDM2 SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk
|
4,51 | 36,05 | Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression
|
0,27 | 2,67 | Identifikace potenciálních biomarkerů karcinomů prsu metodou SELDI-TOF MS
|
12,50 | 50,01 | Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis
|
7,82 | 54,77 | Surface-enhanced laser desorption-ionization/time-of-flight mass spectrometry reveals significant artifacts in serum obtained from clot activator-containing collection devices
|
3,52 | 14,09 | Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity
|
1,56 | 9,36 | Analýza obsahu metalothioneinu u pacientů se zhoubným nádorem prsu, tlustého střeva nebo maligním melanomem
|
Back
(c) Michal Bulant, 2011